COSMO Pharmaceuticals N.V. Registered Shares

(OTC:CMOPF)

By |

Equities News

Company chart and information is provided by TradingView based on 15-minute-delayed data.


Profile

Cosmo Pharmaceuticals NV is a major drug manufacturing company with a focus on specialty pharmaceuticals. Its clinical development pipeline maintains a focus on treatments for inflammatory bowel disease, colorectal cancer diagnosis, and colonoscopy. The company's business model involves identifying market opportunities, creating a corresponding product, advancing through the clinical trials, and then partnering its product into a specialty pharma company with strong marketing and sales expertise by taking an equity stake in the partner. While the equity stake can later be divested, Cosmo retains exclusive manufacturing of all the products it develops.

Contact Information

Website: www.cosmopharma.com
Email: investor.relations@cosmopharmaceuticals.com
Main Phone: +353 18170370
Address: Sir John Rogerson's Quay
Address 2: Riverside II
City / Town: Dublin
Country: IE
Postal Code: 2

Issuer Information

Exchange: GREY
Employees: 265

Equities News

(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume N/A 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange N/A